Advisor Group Holdings, Inc. Lumos Pharma, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $39.8 Billion
  • Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 100 shares of LUMO stock, worth $434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 290 65.52%
Holding current value
$434
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
SELL
$3.54 - $4.45 $672 - $845
-190 Reduced 65.52%
100 $0
Q3 2024

Nov 13, 2024
SELL
$1.45 - $4.05 $29 - $81
-20 Reduced 6.45%
290 $1,000
Q2 2024

Aug 13, 2024
BUY
$2.19 - $3.04 $341 - $474
156 Added 101.3%
310 $0
Q1 2024

May 10, 2024
SELL
$2.64 - $3.22 $11,763 - $14,348
-4,456 Reduced 96.66%
154 $0
Q4 2023

Feb 12, 2024
SELL
$2.81 - $4.27 $8,548 - $12,989
-3,042 Reduced 39.75%
4,610 $14,000
Q3 2023

Nov 13, 2023
BUY
$2.63 - $3.49 $7,221 - $9,583
2,746 Added 55.97%
7,652 $25,000
Q2 2023

Aug 10, 2023
BUY
$3.01 - $4.38 $1,128 - $1,642
375 Added 8.28%
4,906 $16,000
Q1 2023

May 12, 2023
BUY
$3.16 - $4.0 $6,373 - $8,068
2,017 Added 80.23%
4,531 $14,000
Q4 2022

Feb 10, 2023
BUY
$3.05 - $9.52 $3,144 - $9,815
1,031 Added 69.52%
2,514 $9,000
Q3 2022

Nov 14, 2022
SELL
$7.35 - $9.05 $9,547 - $11,755
-1,299 Reduced 46.69%
1,483 $13,000
Q2 2022

Aug 10, 2022
SELL
$6.68 - $9.39 $3,780 - $5,314
-566 Reduced 16.91%
2,782 $22,000
Q1 2022

May 04, 2022
BUY
$6.58 - $10.09 $11,120 - $17,052
1,690 Added 101.93%
3,348 $32,000
Q3 2021

Nov 05, 2021
SELL
$7.36 - $11.36 $5,431 - $8,383
-738 Reduced 30.8%
1,658 $16,000
Q2 2021

Aug 02, 2021
BUY
$9.75 - $13.44 $11,563 - $15,939
1,186 Added 98.02%
2,396 $24,000
Q4 2020

Feb 10, 2021
SELL
$13.61 - $35.91 $26,131 - $68,947
-1,920 Reduced 61.34%
1,210 $42,000
Q3 2020

Nov 12, 2020
SELL
$13.25 - $16.5 $92 - $115
-7 Reduced 0.22%
3,130 $43,000
Q2 2020

Aug 14, 2020
BUY
$7.76 - $16.99 $256 - $560
33 Added 1.06%
3,137 $52,000
Q1 2020

May 18, 2020
BUY
$0.89 - $8.85 $2,762 - $27,470
3,104 New
3,104 $26,000

Others Institutions Holding LUMO

# of Institutions
6
Shares Held
168K
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $36.4M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email